
Synta Announces Presentations at the 2013 American Society for Clinical ...
MarketWatch (press release)
S Hall A2 Presenter: Ahmad Awada, M.D., Institut Jules Bordet, Brussels, Belgium. Investigator-sponsored studies. "A phase II clinical trial of ganetespib (STA-9090) in previously treated patients with advanced esophagogastric cancers". Abstract ...

MEDIGENE AG : publishes final results from phase II Investigator Initiated ...
4-traders (press release)
Dr. Ahmad Awada, Initiator of the IIT and Head of the Medical Oncology Clinic at the Institut Jules Bordet in Brussels, Belgium, commented: "The study results support the promising anti-tumoural effect of EndoTAG ®-1 in combination with weekly ...

Experts say cancer researchers must work together
EurActiv
He spoke at an event hosted by the Organisation of European Cancer Institutes (OECI) at the Jules Bordet Institute in Brussels Tuesday (14 May), as part of the 2013 Oncology Days. "If you can treat the relevant tumours at an earlier stage, the chances ...

Aantal kankergevallen in Europa zal blijven stijgen
Het Laatste Nieuws
Momenteel krijgen patiënten daardoor behandelingen die niet altijd tot een optimaal resultaat zullen leiden, onderstreepte ook directrice Dominique de Valeriola van het Belgische Instituut Jules Bordet. Het is dus erg belangrijk dat onderzoekscentra ...